| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2249.2005.02778.X |
| P8608 | Fatcat ID | release_aub2442e3nh5dgkvzinndsvxmu |
| P932 | PMC publication ID | 1809381 |
| P698 | PubMed publication ID | 15932511 |
| P5875 | ResearchGate publication ID | 7808739 |
| P50 | author | Domenico Ettore Sansonno | Q42848720 |
| P2093 | author name string | F Dammacco | |
| F P Schena | |||
| G Grandaliano | |||
| G Lauletta | |||
| M Montrone | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2 | Q24296260 | ||
| The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus | Q24307963 | ||
| DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans | Q24601035 | ||
| Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients | Q27469952 | ||
| Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. | Q27473066 | ||
| Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay | Q27487862 | ||
| Histological grading and staging of chronic hepatitis | Q29619625 | ||
| Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway | Q30308176 | ||
| Microdissection of histologic sections: past, present, and future | Q30844836 | ||
| Application of laser capture microdissection to proteomics | Q30868586 | ||
| Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis | Q31920335 | ||
| Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay. | Q33197019 | ||
| Renal manifestations of hepatitis C infection | Q33586586 | ||
| Glomerular injury associated with hepatitis C infection: a correlation with blood and tissue HCV-PCR. | Q34785971 | ||
| Hepatitis C and renal disease: an update | Q35547800 | ||
| Viral hepatitis C. | Q35617324 | ||
| Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. | Q42979151 | ||
| Fcγ Receptor-like Activity of Hepatitis C Virus Core Protein | Q42981184 | ||
| Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. | Q42982784 | ||
| Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells | Q42982855 | ||
| Hepatitis C virus RNA in kidney biopsies from infected patients with renal diseases | Q42997743 | ||
| Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication | Q43038550 | ||
| Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosis | Q43039256 | ||
| Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia | Q43040586 | ||
| Hepatitis C virus-associated tubulointerstitial injury | Q43049086 | ||
| Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins | Q43049359 | ||
| RNA amplification in brain tissues. | Q44236316 | ||
| Biophysical characterization of hepatitis C virus core protein: implications for interactions within the virus and host | Q45697410 | ||
| Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. | Q47752721 | ||
| Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20 | Q78728686 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| microdissection | Q4293202 | ||
| P304 | page(s) | 498-506 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection | |
| P478 | volume | 140 |
| Q36782599 | Association of hepatitis C virus infection with prevalence and development of kidney disease |
| Q38528082 | Chronic Kidney Disease--Chronic Liver Disease. An Immunologic Cross-talk |
| Q41542344 | Chronic hepatitis C infection as a risk factor for renal cell carcinoma. |
| Q35823397 | Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis |
| Q41446409 | De Novo Fibrillary Glomerulonephritis (FGN) in a Renal Transplant with Chronic Hepatitis C. |
| Q41937471 | Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. |
| Q37874043 | Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis |
| Q54230120 | Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals. |
| Q30240220 | Global epidemiology and burden of HCV infection and HCV-related disease |
| Q47247097 | HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer |
| Q64244966 | HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents |
| Q38551250 | Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis |
| Q33696523 | Hepatitis C Virus and Nonliver Solid Cancers: Is There an Association between HCV and Cancers of the Pancreas, Thyroid, Kidney, Oral Cavity, Breast, Lung, and Gastrointestinal Tract? |
| Q34263660 | Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis |
| Q92132449 | Hepatitis C virus and risk of extrahepatic malignancies: a case-control study |
| Q37288114 | Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence |
| Q45365524 | Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection |
| Q40981955 | Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010. |
| Q37075834 | Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? |
| Q38123558 | Long-term response to peginterferon in hepatitis C virus-associated nephrotic syndrome from focal segmental glomerulosclerosis |
| Q34128722 | Membranoproliferative glomerulonephritis and mixed cryoglobulinemia after hepatitis C virus infection secondary to glomerular NS3 viral antigen deposits. |
| Q33730265 | Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin |
| Q35868937 | Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. |
| Q35571608 | Risk factors for renal cell carcinoma in the VITAL study |
| Q35013533 | Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden |
| Q88875501 | Secondary IgA nephropathy |
| Q89823605 | Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir |
| Q59072614 | The Unravelled Link between Chronic Kidney Disease and Hepatitis C Infection |
| Q37686155 | Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir |
| Q38220637 | Vasculitis: determinants of disease patterns |
Search more.